Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04969887
Title Combination Immunotherapy in Rare Cancers Under InvesTigation (MOST-CIRCUIT)
Acronym MOST-CIRCUIT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries NZL | AUS

Facility Status City State Zip Country Details
Border Medical Oncology Unit Albury New South Wales 2640 Australia Details
Orange Health Service Orange New South Wales Australia Details
Blacktown Hospital Sydney New South Wales 2145 Australia Details
Calvary Mater Newcastle Waratah New South Wales 2298 Australia Details
Cairns and Hinterland Hospital and Health Service Cairns Queensland 4870 Australia Details
Townsville Hospital and Health Service Douglas Queensland 4814 Australia Details
Townville Hospital and Health Service Townsville Queensland 4814 Australia Details
Royal Adelaide Hospital Adelaide South Australia Australia Details
Royal Hobart Hospital Hobart Tasmania 7000 Australia Details
Bendigo Health Services Bendigo Victoria Australia Details
Peninsula Health Frankston Victoria Australia Details
Barwon Health Geelong Victoria Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Peter MacCalllum Cancer Centre Parkville Victoria Australia Details
Goulburn Valley Health Shepparton Victoria 3630 Australia Details
South West Healthcare Warrnambool Victoria Australia Details
Fiona Stanley Hospital Perth Western Australia Australia Details
Auckland City Hospital Auckland New Zealand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field